BLUE-VIOLET LIGHT PROTECTION
Partial Blue-Violet filtration to support retinal cell survival
CONTRIBUTES TO OVERALL EYE HEALTH
Reduces risk factors associated with harmful light
Lenses remain clear looking through them and at them
Protects your eyes from UVA and UVB rays
EVERYDAY LENS INNOVATION
- Protects your eyes from UV light
- Protects your eyes from Blue-Violet light
- Aesthetically clear
- No residual tint
- No blue reflections on lenses
- Contributes to overall eye health
DO I NEED PROTECTION FROM BLUE LIGHT?
Light is fundamental for our vision and overall well-being. Light allows us to see colours, shapes and details and regulates our cognitive performance, mood and sleep/wake cycle. Parts of the light spectrum can also be the cause of premature eye ageing. The impact from UV rays accumulate overtime and can result in the development of cataracts. Blue-Violet light is present everywhere, mainly from the sun and, in smaller amounts, from LED lighting and is one factor recently identified that can cause damage to retinal cells. By reducing Blue-Violet light exposure can support retinal cell survival.
UNIQUE FILTRATION SYSTEM
Eye Protect System is the first embedded filtration system that will provides protection against harmful light in an aesthetically clear lens. The lens will filter UV and partial Blue-Violet light without a residual tint or hue on the lens so images are clear and your lenses look clear to others.
WE'RE COMMITTED TO TESTING THE BENEFITS.
We conduct systematic wearer tests to guarantee proof of benefits.
tested and rated Essilor lenses in real life conditions
tested Essilor spectacle lenses
on Essilor lenses conducted with consumers
* Harmful light = UV and blue-violet light
** Harmful Blue light: up to 455nm with the greatest toxicity between 415-455nm
*** Orma 1.5 does not absorb 100% UV light.
**** McCarty CA, Taylor HR. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol. 2002; 35:21-31. Sunlight and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch. Ophthalmol., 122, 750-757. New discoveries and therapies in retinal phototoxicity, Serge Picaud et Emilie Arnault, Points de Vue N°68, Spring 2013.